Women’s health is entering a new phase.

The foundations have been built. Capital has flowed. Breakthrough companies have proven the demand. Now we are entering the Era of Scale.

Women’s Health Week USA 2026 is designed around that transition. The theme, Women’s Health 2.0: The Era of Scale, reflects a market moving from validation to institutional adoption. Find out more on our full 2026 program.

This year’s agenda brings together leaders actively shaping that shift. Speakers include executives from Maven Clinic, Organon and Carrot Fertility, investors from Novo Holdings, CVS Health Ventures and Portfolia, and operators from Uber Health, OURA, Clue and Kindbody.

Policy and regulatory voices from the FDA, ARPA-H and Congress will also take the stage, alongside market leaders from Google and the New York Stock Exchange.

Across two days, sessions explore where capital is being deployed, why companies stall at the growth stage, how reimbursement becomes a competitive advantage, what M&A activity signals about consolidation, and how AI and digitisation are reshaping product strategy.

But the real differentiator is how the room is structured.

Women’s Health Week collects structured commercial data from attendees in advance and aligns 1:1 introductions around capital strategy, partnership intent and growth priorities.

The objective is simple: meaningful partnerships, not passive networking.

If women’s health is part of your 2026 strategy, secure your place before midnight on February 27 and save up to $900 on your place with our super early bird pricing.

On December 3–4, 2026 in Boston, Women’s HealthX (WoHX) will bring together 750 global leaders from pharma and biotech, hospitals and health systems, health insurers, employers, investors, startups, and government, all actively seeking proven technologies, data, and partners to advance women’s health care, research, and outcomes across the life course.

WoHX is the number one event in women’s health, unifying the full lifecycle of female healthcare through data, science, and evidence-based innovation to close the sex difference data gap and drive better clinical outcomes for women worldwide

Unlike any other event, WoHX goes beyond discussion to focus on implementation of representative data sets to drive meaningful change. The exhibition directly addresses the conditions that affect women differently and disproportionately, across every stage of life.

Attendees will gain clear insight into which areas are overhyped versus underfunded, where the biggest evidence gaps remain, and how data, science, and evidence can drive measurable change in policy, reimbursement, product development, and clinical practice.

Julie Rios, Division Director, Reproductive Endocrinology & Infertility at UPMC, shared why she is looking forward to attending:

She said: “I’m looking forward to connecting with innovators across women’s health to explore new technologies, collaborations, and care models that can help us solve our most complex reproductive health cases and improve outcomes for patients who currently have limited options.”

Taking place in Boston, the global hub for healthcare innovation, research, and medical institutions, whose collaborative ecosystem aligns perfectly with WoHX’s mission to accelerate the adoption of clinical solutions, and improve outcomes for women worldwide.

Across seven dedicated stages spanning Evidence, Data & Innovation, Fertility & Reproductive Health, Menopause & Healthy Aging, Maternity & Maternal Care, Sexual Health & Wellness, Cognitive Health & Wellness, and Chronic Disease Management, attendees will benefit from:

• 100+ hours of free education from 150+ expert speakers
• Direct access to senior decision-makers and key industry leaders
• Tailored one-to-one meetings with solution providers across medical devices, CROs, and analytics software
• Hands-on exploration of AI-powered tools, digital therapeutics, wearables, telehealth, and integrated care models via the interactive HealthXpo floor, featuring live demonstrations and hands-on clinical showcases
• The Women’s Health Startup Zone, connecting founders directly with investors
• The Career Zone, linking attendees with postgraduate programs, universities, and research centres, alongside masterclasses in AI literacy, data analytics, and research innovation

Early confirmed speakers include:

• Michael Annichine, CEO, Magee-Womens Research Institute and Foundation
• David Friend, Chief Science Officer, Daré Bioscience
• Emily Lau, Director, Women’s Heart Health Program, Brigham and Women’s Hospital
• Carolee Lee, CEO & Founder, WHAM
• Suneela Vegunta, Vice Chair, Women’s Health Research Division, Mayo Clinic
• Barb DePree, Director of Women’s Health, Holland Hospital
• Jodi Neuhauser, Founder & CEO, In Women’s Health
• Julie Rios, Division Director, Reproductive Endocrinology & Infertility, UPMC
• Kesha O’Reilly, Global Director, Medical Affairs HIV Franchise, Gilead Sciences
• Katie Baca-Motes, CEO GSD, Health Research
• Catherine Monk, Founding Director, Center for the Transition to Parenthood
• Mitzi Krockover, CEO & Founder, WomanCentered

Further announcements, including speaker confirmations and agenda highlights, will be released in the coming months.

Because Women’s HealthX believes in healthcare equity, attendance is free for practitioners within pharma, biotech, corporate enterprises, and medical officers and leaders within hospital and healthcare systems.

Register your free place now: https://www.alphaevents.com/events-whx/srspricing#/?utm_source=FemTechW&utm_medium=Media%20Partner&utm_campaign=52531.001%20-%20WHX%20-%20MP%20-%20FemTech%20World%20-%20Press%20Release&utm_term=&utm_content=&disc=&extTreatId=7631829

WHIS, the flagship summit uniting leaders across the women’s health and healthcare innovation  ecosystem, has just announced that the 2026 edition of the event will be hosted at the Encore Boston Harbor.

The summit will take place October 13-15, 2026, bringing together innovators,  investors, policymakers, healthcare providers, payers, and industry partners to accelerate  advancements in women’s health and wellbeing.

WHIS continues to build on its mission to foster cross-sector collaboration, deepen strategic  partnerships, and drive scalable solutions that improve health outcomes and address persistent gaps  in care.

Attendees can expect high-impact keynotes, expert panels, structured networking, and  interactive sessions that span consumer health, digital innovation, clinical advances, and lifespan inclusive care.

Set against the backdrop of one of the region’s most dynamic waterfront destinations, WHIS will  bring together the full health innovation ecosystem for a multi-day gathering focused on accelerating  progress in women’s health, digital transformation, data integration, and scalable care solutions.

Register your interest for the 2026 event at the official event website:

https://whisusa.com/events/whisusa

About WHIS USA

WHIS champions cross-disciplinary collaboration to transform health and wellbeing through  innovation, data-driven insights, digital solutions, and community-centred care.

The summit unites  the full health ecosystem to co-create sustainable solutions that address unmet needs, enhance  member experience, and unlock commercial and clinical impact.